Kinetic analysis of drug release from nanoparticles

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 11, Issue 1, 2008, Pages 167-177

  Barzegar Jalali, Mohammad ^a,b   Adibkia, Khosro ^a,b,c   Valizadeh, Hadi ^a,d   Shadbad, Mohammad Reza Siahi ^a   Nokhodchi, Ali ^a,e   Omidi, Yadollah ^a,b   Mohammadi, Ghobad ^a,f   Nezhadi, Somayeh Hallaj ^a,g   Hasan, Maryam ^a,g  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF KENT   (United Kingdom)

^f KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; DRUG CARRIER; NANOPARTICLE;

ARTICLE; BIOLOGICAL MODEL; CHEMISTRY; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; KINETICS; METABOLISM; METHODOLOGY;

CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; KINETICS; MODELS, BIOLOGICAL; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS;

EID: 53549100748     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3d59t     Document Type: Article

References (64)

1. Lee, V. H. Nanotechnology: challenging the limit of creativity in targeted drug delivery. Adv Drug Deliv Rev, 56: 1527-1528, 2004.
2. Agnihotri, S. A., Mallikarjuna, N. N., and Aminabhavi, T. M. Recent advances on chitosanbased micro-and nanoparticles in drug delivery. J Control Release, 100: 5-28, 2004.
3. Emerich, D. F. Nanomedicine--prospective therapeutic and diagnostic applications. Expert Opin Biol Ther, 5: 1-5, 2005.
4. Manchester, M. and Singh, P. Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging. Adv Drug Deliv Rev, 58: 1505-1522, 2006.
5. Arayne, M. S., Sultana, N., and Noor, U. S. Fabrication of solid nanoparticles for drug delivery. Pak J Pharm Sci, 20: 251-259, 2007.
6. Parveen, S. and Sahoo, S. K. Polymeric nanoparticles for cancer therapy. J Drug Target, 16: 108-123, 2008.
7. Sahoo, S. K., Dilnawaz, F., and Krishnakumar, S. Nanotechnology in ocular drug delivery. Drug Discov Today, 13: 144-151, 2008.
8. Wagner, J. G. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci, 58: 1253-1257, 1969.
9. Costa, P. and Sousa Lobo, J. M. Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13: 123-133, 2001.
10. Barzegar-Jalali, M. A model for linearizing drug dissolution data. Int J Pharm, 63: R6-R11, 1990.
11. Barzegar-Jalali, M. and Dastmalchi, S. Kinetic analysis of chlorpropamide dissolution from solid dispersions. Drug Dev Ind Pharm, 33: 63-70, 2007.
12. Arbos, P., Campanero, M. A., Arangoa, M. A., and Irache, J. M. Nanoparticles with specific bioadhesive properties to circumvent the presystemic degradation of fluorinated pyrimidines. J Control Release, 96: 55-65, 2004.
13. Lu, W., Tan, Y. Z., Hu, K. L., and Jiang, X. G. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier. Int J Pharm, 295: 247-260, 2005.
14. Xiong, X. Y., Tam, K. C., and Gan, L. H. Release kinetics of hydrophobic and hydrophilic model drugs from pluronic F127/poly(lactic acid) nanoparticles. J Control Release, 103: 73-82, 2005.
15. Derakhshandeh, K., Erfan, M., and Dadashzadeh, S. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics. Eur J Pharm Biopharm, 66: 34-41, 2007.
16. Li, Y. P., Zhou, Z. H., Pei, Y. Y., Zhang, X. Y., Gu, Z. H., and Yuan, W. F. PEGylated polycyanoacrylate nanoparticles as salvicine carriers: synthesis, preparation, and in vitro characterization. Acta Pharmacol Sin, 22: 645-650, 2001.
17. Page-Clisson, M. E., Pinto-Alphandary, H., Ourevitch, M., Andremont, A., and Couvreur, P. Development of ciprofloxacin-loaded nanoparticles: physicochemical study of the drug carrier. J Control Release, 56: 23-32, 1998.
18. Dillen, K., Weyenberg, W., Vandervoort, J., and Ludwig, A. The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. Eur J Pharm Biopharm, 58: 539-549, 2004.
19. Jaiswal, J., Gupta, S. K., and Kreuter, J. Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsificationsolvent evaporation process. J Control Release, 96: 169-178, 2004.
20. Thote, A. J. and Gupta, R. B. Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release. Dis Mon, 51: 362-373, 2005.
21. Park, K., Lee, G. Y., Kim, Y. S., Yu, M., Park, R. W., Kim, I. S., Kim, S. Y., and Byun, Y. Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity. J Control Release, 114: 300-306, 2006.
22. Hu, F. Q., Hong, Y., and Yuan, H. Preparation and characterization of solid lipid nanoparticles containing peptide. Int J Pharm, 273: 29-35, 2004.
23. Jiang, B., Hu, L., Gao, C., and Shen, J. Ibuprofen-loaded nanoparticles prepared by a coprecipitation method and their release properties. Int J Pharm, 304: 220-230, 2005.
24. Chaw, C. S., Chooi, K. W., Liu, X. M., Tan, C. W., Wang, L., and Yang, Y. Y. Thermally responsive core-shell nanoparticles selfassembled from cholesteryl end-capped and grafted polyacrylamides:; drug incorporation and in vitro release. Biomaterials, 25: 4297-4308, 2004.
25. Zhenqing, H., Zhenxi, Z., Chuanxin, Z., and Mei, H. Use of natural plant exudates (Sanguis Draxonis) for sustained oral insulin delivery with dramatic reduction of glycemic effects in diabetic rats. J Control Release, 97: 467-475, 2004.
26. Zhang, Q., Shen, Z., and Nagai, T. Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. Int J Pharm, 218: 75-80, 2001.
27. Zhang, Y. and Zhuo, R. X. Synthesis and drug release behavior of poly (trimethylene carbonate)-poly (ethylene glycol)-poly (trimethylene carbonate) nanoparticles. Biomaterials, 26: 2089-2094, 2005.
28. Teixeira, M., Alonso, M. J., Pinto, M. M., and Barbosa, C. M. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur J Pharm Biopharm, 59: 491-500, 2005.
29. Xiong, X. Y., Tam, K. C., and Gan, L. H. Effect of enzymatic degradation on the release kinetics of model drug from Pluronic F127/poly(lactic acid) nano-particles. J Control Release, 108: 263-270, 2005.
30. Yin, W., Akala, E. O., and Taylor, R. E. Design of naltrexone-loaded hydrolyzable crosslinked nanoparticles. Int J Pharm, 244: 9-19, 2002.
31. Hecq, J., Deleers, M., Fanara, D., Vranckx, H., and Amighi, K. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm, 299: 167-177, 2005.
32. Jeon, H. J., Jeong, Y. I., Jang, M. K., Park, Y. H., and Nah, J. W. Effect of solvent on the preparation of surfactant-free poly(DL-lactideco-glycolide) nanoparticles and norfloxacin release characteristics. Int J Pharm, 207: 99-108, 2000.
33. Mu, L. and Feng, S. S. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release, 86: 33-48, 2003.
34. Lee, J., Cho, E. C., and Cho, K. Incorporation and release behavior of hydrophobic drug in functionalized poly(D, L-lactide)-blockpoly(ethylene oxide) micelles. J Control Release, 94: 323-335, 2004.
35. Mainardes, R. M. and Evangelista, R. C. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm, 290: 137-144, 2005.
36. Wei, H., Zhang, X., Cheng, C., Cheng, S. X., and Zhuo, R. X. Self-assembled, thermosensitive micelles of a star block copolymer based on PMMA and PNIPAAm for controlled drug delivery. Biomaterials, 28: 99-107, 2007.
37. Govender, T., Stolnik, S., Garnett, M. C., Illum, L., and Davis, S. S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release, 57: 171-185, 1999.
38. Matsumoto, J., Nakada, Y., Sakurai, K., Nakamura, T., and Takahashi, Y. Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro. Int J Pharm, 185: 93-101, 1999.
39. Sant, S., Nadeau, V., and Hildgen, P. Effect of porosity on the release kinetics of propafenoneloaded PEG-g-PLA nanoparticles. J Control Release, 107: 203-214, 2005.
40. Leroux, J. C., Allemann, E., De Jaeghere, F., Doelker, E., and Gurny, R. Biodegradable nanoparticles from sustained release formulations to improved site specific drug delivery. J Control Release, 39: 339-350, 1996.
41. Hu, Y., Jiang, X., Ding, Y., Ge, H., Yuan, Y., and Yang, C. Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles. Biomaterials, 23: 3193-3201, 2002.
42. Hu, F. X., Neoh, K. G., and Kang, E. T. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. Biomaterials, 27: 5725-5733, 2006.
43. Malzert-Freon, A., Vrignaud, S., Saulnier, P., Lisowski, V., Benoit, J. P., and Rault, S. Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agent. Int J Pharm, 320: 157-164, 2006.
44. Noyes, A. and itney, W. The rate of solution of solid substances in their own solutions. J Am Chem Soc, 19: 934, 1897.
45. Higuchi, T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci, 50: 874-875, 1961.
46. Higuchi, T. Mechanism of sustained-action medication. Theoretical analysis of release of solid drugs dispersed in solid matrices. J Pharm Sci, 52: 1145-1149, 1963.
47. Macheras, P. and Dokoumetzidis, A. On the heterogeneity of drug dissolution and release. Pharm Res, 17: 108-112, 2000.
48. Washburn, E. W. The dynamics of capillary flow. PHYSICAL REVIEW, 17: 273-283, 1921.
49. Peppas, N. A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 60: 110-111, 1985.
50. Ritger, P. L. and Peppas, N. A. A simple equation for description of solute release. I. Fickian and anomalous release from swellable devices. J Control Release, 5: 37-42, 1987.
51. Harland, R. S., Gazzaniga, A., Sangalli, M. E., Colombo, P., and Peppas, N. A. Drug/polymer matrix swelling and dissolution. Pharm Res, 5: 488-494, 1988.
52. Peppas, N. A. and Sahlin, J. J. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm, 57: 169-172, 1989.
53. Langenbucher, F. Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmacol, 24: 979-981, 1972.
54. Lin, S. Y. and Kawashima, Y. Drug release from tablets containing cellulose acetate phthalate as an additive or enteric-coating material. Pharm Res, 4: 70-74, 1987.
55. Chen, D. B., Yang, T. Z., Lu, W. L., and Zhang, Q. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. Chem Pharm Bull (Tokyo), 49: 1444-1447, 2001.
56. Morales, M. E., Gallardo, L., V, Calpena, A. C., Domenech, J., and Ruiz, M. A. Comparative study of morphine diffusion from sustained release polymeric suspensions. J Control Release, 95: 75-81, 2004.
57. Venkateswarlu, V. and Manjunath, K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release, 95: 627-638, 2004.
58. Zeo, U., Tarabukina, E., and Budtova, T. Kinetics of shear-induced gel deswelling/solvent release. J Control Release, 108: 73-83, 2005.
59. Pattarino, F., Giovannelli, L., and Bellomi, S. Effect of poloxamers on nifedipine microparticles prepared by Hot Air Coating technique. Eur J Pharm Biopharm, 2006.
60. Raffin, R. P., Colome, L. M., Pohlmann, A. R., and Guterres, S. S. Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. Eur J Pharm Biopharm, 63: 198-204, 2006.
61. Papadopoulou, V., Kosmidis, K., Vlachou, M., and Macheras, P. On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm, 309: 44-50, 2006.
62. Adibkia, K., Siahi Shadbad, M. R., Nokhodchi, A., Javadzedeh, A., Barzegar-Jalali, M., Barar, J., Mohammadi, G., and Omidi, Y. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis. J Drug Target, 15: 407-416, 2007.
63. Liu, J., Gong, T., Wang, C., Zhong, Z., and Zhang, Z. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholinebased mixed micelles: preparation and characterization. Int J Pharm, 340: 153-162, 2007.
64. Lippmann, I. Curve fitting of dissolution data from solid dosage form with the assistance of a digital computer. In L. J. Leeson and J. T. Corstensen (eds.), Dissolution technology, Washington D.C., 1974.